Abstract | BACKGROUND AND AIMS: METHODS: Patients undergoing > 3/4 circumferential ESD were randomized to either the endoscopic loco-regional triamcinolone acetonide injection (ETI) plus oral prednisone group or the OHA group. The primary endpoint was incidence of esophageal stricture, and the secondary endpoints included adverse events (AEs) and endoscopic balloon dilations (EBDs). RESULTS: The incidence of esophageal stricture in OHA group (per-protocol analysis, 9.4%, 3/32; intention-to-treat analysis, 12.1%, 4/33) was significantly less than that of control group (per-protocol analysis, 35.5%, 11/31, P = 0.013; intention-to-treat analysis, 39.4%, 13/33, P = 0.011). Two sessions of EBD were necessary to release all strictures in the OHA group, while the similar EBDs (median 2, range 1-4) for 11 of the control. Operation-related AEs included infection (control vs. OHA group = 9.7% vs. 31.3%, P = 0.034), operation-related hypokalemia (19.4% vs. 31.3%, P = 0.278), perforation (3.2% vs. 3.1%), post-ESD hemorrhage (6.5% vs. 0%), and cardiac arrhythmia (0% vs. 6.3%). Steroid-related AEs included steroid-related hypokalemia (16.1% vs. 25%) and bone fracture (3.2% vs. 0%). Multivariate logistic regression analysis demonstrated that OHA was an independent protective factor for stricture (OR 0.079; 95%CI 0.011, 0.544; P = 0.01) and mucosal defect > 11/12 circumference was an independent risk factor (OR 49.91; 95%CI 6.7, 371.83; P < 0.001). CONCLUSIONS:
|
Authors | Yiyang Zhang, Xiue Yan, Yonghui Huang, Dan Nie, Yingchun Wang, Hong Chang, Yaopeng Zhang, Wei Yao, Ke Li |
Journal | Surgical endoscopy
(Surg Endosc)
Vol. 36
Issue 1
Pg. 402-412
(01 2022)
ISSN: 1432-2218 [Electronic] Germany |
PMID | 33492500
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature. |
Chemical References |
|
Topics |
- Endoscopic Mucosal Resection
(adverse effects)
- Esophageal Neoplasms
(complications)
- Esophageal Stenosis
(etiology, prevention & control)
- Humans
- Steroids
- Triamcinolone
|